NIAID Centers of Excellence for Influenza Research and Response

This Broad Agency Announcement from the National Institutes of Health National Institute of Allergy and Infectious Diseases solicits proposals to establish multiple Centers of Excellence for Influenza Research and Response through cost reimbursement contracts. Proposals are due by March 2, 2020 and must focus on studying influenza viruses in humans and at interspecies interfaces, as well as providing infrastructure for emergency response. Evaluation will consider technical merit and cost/price factors, as well as plans for human subjects research, animal studies, and data sharing. Questions were addressed on November 7, 2019 and December 10, 2019.

No set-aside is designated. Research will involve basic and clinical studies of influenza virology, immunology, pathogenesis, transmission, epidemiology, and countermeasure development under NAICS codes 541715 and PSC codes D301 and R425. Multiple awards are anticipated to be made by December 31, 2020 totaling an estimated average annual cost of $20 million. Studies will be conducted over an initial five-year base period ending December 30, 2025 with options to extend. Proposals must include a minimum of one domestic surveillance site and two international sites in Asia, Africa or Latin America.